Humacyte reports Q4, full-year results

Humacyte released its fourth quarter and full-year financial results for 2025, reporting total revenues of $0.5 million for the quarter and $2.0 million for the full year from sales and research collaborations. The company also provided a business update, including details on purchase commitments. These figures offer insight into the company's financial performance and ongoing operational activities.